Winners
Phase 2 winners
Meridian Bioscience
Technological Advances in Electrochemical Blood Lead Detection at Point-of-care
First-place winner Meridian Bioscience is using electrochemical sensors to detect lead by measuring the electrical current in a blood sample.
OndaVia
Quantitative Raman Spectroscopy for Lead in Blood
Second-place winner OndaVia is applying optical technology to detect the presence of lead using a distinctive fingerprint signature.
GlucoSentient and UT Austin
Point-of-care test for lead in blood using DNAzyme and glucometer
Third-place winner GlucoSentient is adapting a blood glucose meter platform and using a DNAzyme sensor to detect lead in a blood sample.
Phase 1 winners
Fluorezyme
Advancing Blood Lead Analysis with FLUOREZYME Dual Amplification Strategy
Fluorezyme’s dual amplification strategy would use DNA and light to detect lead in whole blood with a device that would fit in a user’s hand.
GlucoSentient and UT Austin
Point-of-care test for lead in blood using DNAzyme and glucometer
The concept from GlucoSentient and UT Austin would adapt a blood glucose meter platform and use a DNAzyme sensor to detect lead in a blood sample.
Meridian Bioscience
Technological Advances in Electrochemical Blood Lead Detection at Point-of-care
Meridian Bioscience’s device would apply electrochemical sensors to detect lead by measuring the electrical current in a blood sample.
OndaVia
Quantitative Raman Spectroscopy for Lead in Blood
OndaVia’s solution would apply optical technology to detect the presence of lead using a distinctive fingerprint signature.
SensiLead
SensiLead: plug and play sensor for Blood Lead levels detection
SensiLead’s plug-and-play sensor would apply electrochemistry to detect lead and include a mobile app that would allow users to test and track results.